TreatmentUpdate
213

February 2016 

Zepatier for hepatitis C approved in Canada

Zepatier is a fixed-dose pill containing the following two anti-HCV drugs:

  • elbasvir – 50 mg
  • grazoprevir – 100 mg

Zepatier is taken once daily with or without food.

The story Zepatier for hepatitis C approved in Canada first appeared in CATIE News and we include it here as part of a package on Zepatier-related information. It is important to note that this story contains a summary of key information about Zepatier and in which patient populations it can be used.

—Sean R. Hosein

Do you work in HIV or hep C?
Complete a short survey to evaluate CATIE and enter a draw to win a $250 gift card.